Systemic Light Chain Amyloidosis clinical trials

Explore recruiting systemic light chain amyloidosis clinical trials.

Recruiting systemic light chain amyloidosis studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Systemic Light Chain Amyloidosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 1/2 Study of Linvoseltamab in Patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Spain, Greece

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Systemic Light Chain Amyloidosis trials by city

Systemic Light Chain Amyloidosis clinical trials

Recruiting systemic light chain amyloidosis studies right now

3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis Patients

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

Daratumumab for Patients With Light Chain Amyloidosis

Optimize First-line Treatment for AL Amyloidosis With t (11; 14)

Prospective Study of Teclistamab in the Treatment of Systemic AL Amyloidosis

A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory Systemic Light Chain Amyloidosis (AL Amyloidosis)

Autologous BCMA-targeted CAR-T Cell Injection for Relapsed/Refractory Light Chain Amyloidosis

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis (NDSLCA)

Also recruiting in Europe

A Phase 1/2 Study of Linvoseltamab in Patients with Relapsed or Refractory Systemic Light Chain Amyloidosis

Systemic Light Chain Amyloidosis trials by city

Other conditions